Delivery Order SPE2DR25D3103-SPE2DR26F9M12
- Not listed
- The Defense Logistics Agency awarded a $17,911.04 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,631.11 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The contract does not carry a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $13,924.72. The award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency has awarded a delivery order valued at $18,417.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,176.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,362.53 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on December 4, 2025, with completion scheduled for December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order valued at $10,908.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, issued on July 28, 2025, is expected to be completed by July 29, 2025. The award represents a non-competitive set-aside contract executed through AmerisourceBergen's existing indefinite delivery vehicle with DLA Troop Support Medical. The product will be delivered to the contractor's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M12Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,670.15 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive delivery order executed without set-aside provisions. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications to support military and veteran healthcare systems. The Jardiance order fulfills critical pharmaceutical supply requirements within the Defense Health Agency's medical supply chain, reflecting the company's ongoing role as a prime vendor for diabetes and specialty medications supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 12/4/25 |